JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 85 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $549,000 | +17.1% | 234,294 | +51.4% | 0.01% | 0.0% |
| Q2 2022 | $469,000 | -51.0% | 154,728 | +9.7% | 0.01% | -44.4% |
| Q1 2022 | $958,000 | -25.6% | 141,090 | -8.5% | 0.01% | -25.0% |
| Q4 2021 | $1,288,000 | +48.6% | 154,190 | +32.0% | 0.01% | +33.3% |
| Q3 2021 | $867,000 | -2.0% | 116,784 | -10.2% | 0.01% | 0.0% |
| Q2 2021 | $885,000 | -58.7% | 130,012 | -37.7% | 0.01% | -65.4% |
| Q1 2021 | $2,144,000 | +330.5% | 208,812 | +837.2% | 0.03% | -29.7% |
| Q1 2018 | $498,000 | – | 22,280 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |